12 Integrating Technology in Facial Plastic Surgery Summary This chapter discusses the role of technology in facial plastic surgery. We will analyze the methods and influences that affect physician and patient choices and discuss the role of industry and the Internet in educating and biasing patients. We will also consider the many factors that influence every practitioner, such as economics, ego, industry advertising, and skill level. Keywords: adipocytolysis, advertising, biases, cryolipolysis, decision-making, deoxycholic acid, direct-to-consumer advertising (DTCA), facial analysis, hair restoration, laser technology, lipolysis, liposuction, online marketing, patient expectations, push marketing, social media, technology, ultrasonic energy therapy Key Points • An essential element of a facial plastic surgery practice is the ability to critically evaluate newer and emerging technology and the resulting investment. • An effective marketing strategy is critical to support the success of a facial plastic surgeon. • Direct-to-consumer advertising and social media can influence patients and have changed the means of exposure to new companies and devices. Each time that a facial plastic surgery patient requests alteration in facial appearance and/or function, the practitioner faces a decision-making process that includes several factors: the wants and desires of the patient, the facial analysis, the psychological composition of the patient, and the inherent biases and skills of the surgeon. Of course, the specific requests of an individual patient are of paramount importance in shaping the discussion regarding procedure choice. The change (s) that the patient is seeking should always be the most important factor in deciding which recommendations to make. After considering the patient’s goals, the surgeon should then discuss the therapeutic treatment options. This dialogue is important in educating and empowering each patient. The communication that occurs during the initial consultation plays a significant role in determining whether the patient’s expectations can be met and if the procedures suggested will accomplish the patient’s desires. This process is as important a factor in determining patient satisfaction as is the performance of the procedure itself. The best therapeutic option for any patient may be a single procedure or a combination of procedures and technologies. The practitioner’s individual skill, comfort level, and personal bias influence what procedure (s) is recommended. It is the duty of each practitioner to use the best evidence regarding any procedure or technology before suggesting this to any patient. It is only after being presented this evidence that the patient can make an informed choice on any given procedure. This chapter will discuss the role of technology in facial plastic surgery. Specifically, the methods and influences that affect physician and patient choices will be analyzed. The role of industry and the Internet in educating and biasing patients will also be discussed. Finally, the factors that influence every practitioner—economics, ego, industry advertising, and skill level—will be considered. The Internet has been a vehicle to globalize facial plastic surgery. It has contributed to the increase in the frequency of procedures, has improved access to patient education, and has allowed plastic surgeons to advertise their skills and market their practices. Physicians realize that patients relish the ability to research their doctor and his or her practice. Patients often cannot discriminate between fact and fiction, and the information provided on the Internet is not monitored for reliability or accuracy. Patients commonly request new procedures, products, or technologies. They often feel that what is new is desirable. To many patients, recently adopted procedures with marketed names afford an advantage over more established procedures and technologies. It is common for a plastic surgery patient to ask their practitioner, “Do you have anything new?” or “Are there any new techniques that you are using?” Patients are frequently persuaded by physicians who market their new or “special” technique, or by the industry that markets their product as “the best.” The combination of the patient wanting the “latest and greatest” and the physician wanting to sell their product and/or services often makes the patient prey to misleading predictions of outcomes. Advertising and marketing is an important component of practice in plastic surgery. Individuals who practice any aspect of cosmetic medicine realize that success in their practice is related to their ability to advertise their products and to market their skills. Aesthetic surgery and related aesthetic services are “created wants,” not needs. Advertising makes patients aware of the services offered and is an avenue for physicians to educate the public about the credentials and experience of the physician. The Internet is also a tremendous vehicle to disseminate information and to describe new technologies and services. Two main strategies exist in advertising aesthetic products and services: push and pull marketing campaigns. Each of these strategies is well suited for certain types of offerings provided by facial plastic surgeons and can also be inefficient and unproductive uses of valuable resources when applied in the wrong setting. In pull marketing strategies, consumers who are already engaged in a relationship with the seller are given information about products during ongoing consultation. This is a more familiar archetype for facial plastic surgeons, because the discussion of options for facial rejuvenation often lends itself well to an introduction of new products or procedures. Examples include introducing a patient to a new facial filler or skin resurfacing device while weighing rejuvenative options. Because patients will often see not only the surgeon but also the aesthetician and clinic staff, it is imperative that all staff are aware of the new offerings and can introduce them when relevant. The penetrative exposure of pull marketing is low, but the yield is higher than with push marketing and it has the additive ability to foster trust and build the surgeon–patient relationship. Both pull and push marketing are useful to inform patients of the goods and services provided in facial plastic surgery. The ideal blend varies based on the spectrum of offerings, the degree of establishment of a practice, and the age and demographics of the clientele, and it can even vary geographically. This is also based on the practice blend of each individual office. Offices that provide cash-based facial aesthetic services in addition to functional insurance-based services will likely find that a different strategy is beneficial to that of a full-time cosmetic practice. Hybrid practices may use more push marketing, because the patients there may not be aware of these services, and sometimes this can be as simple as displaying flyers or providing educational materials in the clinic waiting room. Full-time aesthetic practices will likely have relatively more pull marketing, because patients are already presenting for rejuvenation, but these practices should also employ push marketing to a certain degree to attract new clientele to the office. Regardless of the approach, it is imperative to continually re-evaluate the efficacy of a practice’s marketing strategy to ensure that resources are not being wasted and that the return on investment of advertising is acceptable. See Table 12.1 for a summary and comparison. Medical device companies play an important role in plastic surgery practices. They fund technology that creates new devices, which expand the services provided to patients. Increasing technology positively impacts physicians’ practices, and can improve the overall aesthetic results for patients. Creating these new technologies requires funding that would not be possible without companies willing to raise capital in an effort to capitalize on these technologies. Of course, the main goal of medical device companies is profit. The process for companies to create profit is to stimulate a new idea, to create and fund the technology, and then to market and sell it. Selling the technology involves marketing the device to the physician and direct-to-consumer advertising (DTCA). In some ways, DTCA by industry can benefit the aesthetic surgery market and individual physician practices. However, it is common for drug and device companies to inflate the efficacy and downplay the safety issues related to their drug or device. Industry in medicine often gets a product FDA-approved and then markets the product without an adequate scientific basis. The model—the product, followed by marketing, then followed possibly by science—can be deceptive to the public. Physicians cannot rely on the statements of manufacturers to ensure the validity of claims often made by companies to sell products. It is the responsibility of the physician to not just repeat the manufacturer’s party line, but also to confirm the accuracy of their claims. This is done by carefully analyzing aesthetic outcomes and monitoring patient satisfaction from new devices and procedures. For many years, the only means to reduce fat volume was with a surgical procedure. In the body, this required liposuction (with or without abdominoplasty or other body lift). In the neck, submental liposuction with or without neck lifting or facelifting was the only treatment. More recently, devices and injectable drugs that create lipolysis and tighten the soft tissues have been designed, giving the patient and practitioner alternatives to surgery (see Video 2.11). Table 12.1 A Summary and Comparison of Marketing Strategies
12.1 Introduction
12.2 Patient Desires
12.3 Physician Advertising
12.4 The Role of Industry
12.5 Skin Tightening and Fat Reduction
| Push Marketing | Pull Marketing |
Visibility/exposure | High | Low |
Yield (patients who pursue product/service based on marketing) | Low | High |
Target audience | Those who have not considered/are unaware of procedure/product | Patients already seeking aesthetic improvement |
Ideal practice | Both hybrid practices and pure aesthetic | Pure aesthetic |
12.5.1 Deoxycholic Acid
An injectable form of deoxycholic acid, Kybella (keoxycholic acid, Allergan, Inc.) has been FDA approved for infiltration into the preplatysmal fat for the reduction of submental fat (see Product Index (p. 170)).1,2,3,4 When injected subcutaneously into fat, Kybella causes adipocytolysis, and stimulates a local tissue response consisting of macrophage infiltration (to remove cellular debris and liberated lipids), fibroblast recruitment, and collagen production (neocollagenesis).3 The desired effect is to improve the submental contour and decrease submental fullness. The treatment process is performed as a 20-minute procedure in an office setting and usually requires 2 to 4 treatments to achieve maximal improvement in neck contour.1 This technique has minimal downtime and can often replace submental liposuction, in addition to having off-label potential for body contouring in other areas.5
12.5.2 CoolSculpting
The recently developed CoolSculpting (ZELTIQ Aesthetics, Inc.) device utilizes thermogenic damage of superficial adipocytes to induce what the company has named cryolipolysis (see Product Index (p. 180)). For days to weeks following the treatment, the damaged adipose tissue is cleared by macrophages and neutrophils and theoretically results in a reduction of the superficial fatty tissue.6 The length of the procedure is approximately 60 minutes on average, and effects can be apparent in weeks to months after the procedure. Most patients will have 1 to 2 treatments depending on the individual patient response and patient preference.
The CoolSculpting device is FDA-approved for use in the abdomen, thigh, flank, back, axilla, and submental areas, and it is sometimes used off-label in other areas as well.7,8 Advantages to CoolSculpting treatments are that it is noninvasive and does not require an anesthetic or incision. There is virtually no postprocedure downtime, and there is minimal discomfort to the patient during and after the procedure. Side effects are mild and include temporary erythema and ecchymosis, paresthesia/numbness, and mild pain, with severe complications exceedingly rare.7 In those patients who are surgery-averse, Cool-Sculpting offers a reasonable option for improvement in body contour. Also, because this procedure can be performed by a nurse, technician, or aesthetician, it does not require a large time commitment by the surgeon. Disadvantages to the treatment include inconsistent results and the repeated or additional treatments required by some patients. The cost averages approximately $2000 per treatment, but this amount varies geographically. From a cost perspective, a fair amount of the charges are composed of relatively high-cost consumables, particularly the applicators. As far as the durability of results, long-term data has not yet been published. This makes it difficult to communicate the predictability of the treatment to patients. Anecdotally, practitioners find that if the patient gains body weight during the postprocedure period, the results are somewhat truncated.
12.5.3 Ultherapy
Ultherapy (Ulthera, Inc.) is designed as a skin-tightening device that uses ultrasonic energy to induce collagen production and deposition in the subcutaneous tissues (see Product Index (p. 185)). Using a combined imaging and treatment ultrasound probe, the Ultherapist provides pulses of ultrasound at various depths of the subdermis and superficial fat.9 Treatments average approximately 60 minutes depending on the number of area (s) treated. Ultherapy is FDA-approved for use in the neck, upper chest, and brow, and its off-label uses include the midface and other areas of the body.10
Advantages of the Ultherapy procedure include another non-surgical and scarless approach to induce facial rejuvenation, with little to no downtime and postprocedure healing ( Fig. 12.1). Also, the Ultherapist does not have to be an MD or nurse in most U.S. states, thus providing an opportunity cost-benefit in freeing the surgeon for other productivity. The therapy has also been shown to be safe with relatively few complications.
The major disadvantages of Ultherapy is the variability of results and some patients may even report worsening of their skin laxity. Also, the procedure itself can be somewhat uncomfortable and even painful, sometimes requiring oral analgesics or anxiolytics.9 The device is quite expensive to purchase, and the consumables have similarly high prices, which often translates into bigger charges to the patients, averaging $2,000 to $3,000 with additional charges for added subsites.